目錄:MedChemExpress LLC>>生化試劑>> AZD8330 | MCE
CAS | 869357-68-6 | 純度 | 99.14% |
---|---|---|---|
分子量 | 461.23 | 分子式 | C??H??FIN?O? |
供貨周期 | 現(xiàn)貨 | 規(guī)格 | 2 mg |
貨號 | HY-12058 | 應用領域 | 醫(yī)療衛(wèi)生,化工,生物產業(yè),制藥 |
MCE 的所有產品僅用作科學研究或藥證申報,我們不為任何個人用途提供產品和服務,。
CAS No. : 869357-68-6
產品活性:AZD8330 (ARRY-424704) is a potent, uncompetitive MEK1/MEK2 inhibitor, with an IC50 of 7 nM.
研究領域:MAPK/ERK Pathway
作用靶點:MEK
In Vitro: AZD8330 is a selective allosteric MEK1/ MEK2 inhibitor. Exposing human osteosarcoma cell lines MOS, U2OS, and 143B to a concentration of 0.5 μM of Trametinib, AZD8330 or TAK-733 for 6 hours, leads to loss of ERK phosphorylation indicating effective MEK inhibition.The activity of these three inhibitors is tested using concentration ranges in six osteosarcoma cell lines: MOS, U2OS, KPD, ZK58, 143b and Saos-2. All three inhibitors decrease viability of MOS and U2OS and strongly affect 143b. By contrast, viability of KPD, ZK58 and Saos-2 is not affected by any of the three inhibitors.
In Vivo: In tumour xenograft models, AZD8330 demonstrates dose-dependent tumour growth inhibition of approximately 90% at tolerated doses (1.0 mg/kg once daily [OD]).
相關產品:Clinical Compound Library Plus | Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | Kinase Inhibitor Library | MAPK Compound Library | Anti-Cancer Compound Library | Clinical Compound Library | Reprogramming Compound Library | Oxygen Sensing Compound Library | Ferroptosis Compound Library | Glutamine Metabolism Compound Library | Anti-Pancreatic Cancer Compound Library | Anti-Obesity Compound Library | Angiogenesis-Related Compound Library | Targeted Diversity Library | Anti-Liver Cancer Compound Library | Anti-Colorectal Cancer Compound Library | Pain-Related Compound Library | Avutometinib | Cobimetinib racemate | Trametinib (DMSO solvate) | PD184161 | GW284543 hydrochloride | trans-Zeatin-d5 | BI-847325 | Hypothemycin | Debromohymenialdisine | RGB-286638 | Binimetinib | Trametinib-d4 | Gossypetin | Lidocaine-d10 (hydrochloride) | Isorhamnetin | MS432 | MEK1/2-IN-2 | Trametinib-13C6 | MEK-IN-5 | Lidocaine hydrochloride hydrate | PD 198306 | CI-1040 | (R)-PD 0325901CL | MEK/PI3K-IN-1 | GDC-0623 | N-Oxide Lidocaine-d10 | TAK-733
熱門產品線:重組蛋白 | 化合物庫 | 天然產物 | 熒光染料 | PROTAC | 同位素標記物 | 寡核苷酸 | 抗體 | 點擊化學
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種*僅有化合物庫,,我們致力于為*科研客戶提供前沿的高品質小分子活性化合物;
• 50,000 多種高選擇性抑制劑,、激動劑涉及各熱門信號通路及疾病領,;
• 產品種類涵蓋各種重組蛋白,多肽,,常用試劑盒 ,,更有 PROTAC、ADC 等特色產品,,廣泛應用于新藥研發(fā),、生命科學等科研項目;
• 提供虛擬篩選,,離子通道篩選,,代謝組學分析檢測分析,藥物篩選等專業(yè)技術服務,;
• 設有專業(yè)的實驗中心和嚴格的質控,、驗證體系;
• 提供 LC/MS,、NMR,、HPLC、手性分析,、元素分析等各項質檢報告,,確保產品的高純度、高品質,;
• 產品的生物活性多經各國客戶實驗驗證,;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果;
• 專業(yè)團隊跟蹤最新的制藥及生命科學研究進展,,為您提供*新的活性化合物,;
• 與世界各大制藥公司及著名科研機構建立了長期的合作。